Correction: The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial
- PMID: 31154319
- PMCID: PMC6549671
- DOI: 10.1136/bmjopen-2018-026590corr1
Correction: The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial
Erratum for
-
The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial.BMJ Open. 2019 Mar 30;9(3):e026590. doi: 10.1136/bmjopen-2018-026590. BMJ Open. 2019. PMID: 30928954 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous